Shawn Carbonell, MD, Cofounder and CEO of Brazen Bio Inc.

Inside Biotech

Shawn Carbonell, MD, PhD, is Cofounder and CEO of Brazen Bio Inc. and Cofounder and Managing Partner of Brazen Capital. He is a graduate of the University of Virginia Medical Scientist Training Program and completed postdocs at Oxford University and UCSF. After a major discovery in brain cancer, Dr. Carbonell quit neurosurgery residency to cofound his first biotech startup, OncoSynergy, Inc. He raised over $20M in dilutive and non-dilutive funding and led the development of the first-in-class therapeutic he invented, OS2966. Today—at Brazen Bio—his mission is to establish the “Y Combinator of biotech,” to help founders overcome the tremendous obstacles that are unique to this industry — obstacles that he personally faced when starting his first company. He sees great value in encouraging more scientists to become CEOs to launch novel technologies beyond the laboratory to advance human health. To learn more, visit his website, https://www.brainsurgerydropout.com.

Check out bc-la.org for upcoming events, more information on the organization, and lots of exciting updates.

Follow our Instagram @insidebiotech for updates about episodes and upcoming guests!

To learn more about BCLA’s events and consulting visit our website.

Follow BCLA on LinkedIn